초록 ▼

This invention relates to a multilayered film for use as in-mold label, comprising: a core layer having a first surface and a second surface, the core layer being comprised of a polymeric material and particulate solids dispersed in the polymeric material; and a first skin layer overlying the first

This invention relates to a multilayered film for use as in-mold label, comprising: a core layer having a first surface and a second surface, the core layer being comprised of a polymeric material and particulate solids dispersed in the polymeric material; and a first skin layer overlying the first surface of the core layer; the film being formed by co-extruding the core layer and first skin layer to form the multilayered film, hot-stretching the film at a temperature above the expected service temperature of the label to provide the film with a machine direction orientation, the density of the film being reduced by about 5% to about 25% during hot-stretching, and annealing the film at a temperature above the expected service temperature of the label; the film having a machine direction Gurley stiffness value in the range of about 30 to about 120, a machine direction shrinkage of less than about 2%, and a machine direction shrink tension at 200° F. (93.3° C.) of less than about 100 psi.

대표청구항 ▼

This invention relates to a multilayered film for use as in-mold label, comprising: a core layer having a first surface and a second surface, the core layer being comprised of a polymeric material and particulate solids dispersed in the polymeric material; and a first skin layer overlying the first

This invention relates to a multilayered film for use as in-mold label, comprising: a core layer having a first surface and a second surface, the core layer being comprised of a polymeric material and particulate solids dispersed in the polymeric material; and a first skin layer overlying the first surface of the core layer; the film being formed by co-extruding the core layer and first skin layer to form the multilayered film, hot-stretching the film at a temperature above the expected service temperature of the label to provide the film with a machine direction orientation, the density of the film being reduced by about 5% to about 25% during hot-stretching, and annealing the film at a temperature above the expected service temperature of the label; the film having a machine direction Gurley stiffness value in the range of about 30 to about 120, a machine direction shrinkage of less than about 2%, and a machine direction shrink tension at 200° F. (93.3° C.) of less than about 100 psi. ethsen; US-5544646, 19960800, Lloyd et al.; US-5694919, 19971200, Rubsamen et al.; US-5724957, 19980300, Rubsamen et al.; US-5735263, 19980400, Rubsamen et al.; US-5758637, 19980600, Ivri et al.; US-5915378, 19990600, Lloyd et al.; US-5934272, 19990800, Lloyd et al.; US-5957124, 19990900, Lloyd et al.; US-5960792, 19991000, Lloyd et al.; US-5993805, 19991100, Sutton et al.; US-6041777, 20000300, Faithfull et al., 128/200.24; US-6051566, 20000400, Bianco; US-6095134, 20000800, Sievers et al.; US-6095153, 20000800, Kessler et al.; US-6102036, 20000800, Slutsky et al.; US-6299900, 20011000, Reed et al.; US-6306431, 20011000, Zhang et al.; US-6514482, 20030200, Bartus et al., 424/045; US-6591839, 20030700, Meyer et al.; US-20020058009, 20020500, Bartus et al.; US-20020061281, 20020500, Osbakken et al.; US-20030032638, 20030200, Kim et al. ols in the forms α, β, γ, and δ; and tocotrienols in the forms α, β, γ, and δ. 9. The formulation of claim 8 wherein said Vitamin E as dl-α-tocopheryl ester, said Vitamin E as d-α-tocopherol, and said Vitamin E mixed tocopherols in the forms α, β, γ, and δ is a blend of synthetic and natural sources of Vitamin E, and said tocotrienols are from a natural source. 10. The formulation of claim 8 wherein said Vitamin E as dl-α-tocopheryl ester is present at from 5 mg to 2000 mg. 11. A formulation beneficial as a 400 IU once daily adult dose for antioxidant protection of cells in the human body containing a lipid bilayer membrane comprised of: Vitamin E selected from at least one of the ester group consisting of: dl-α-tocopheryl acetate; and dl-α-tocopheryl succinate; Vitamin E as d-α-tocopherol; Vitamin E mixed tocopherols in the forms α, β, γ, and δ; tocotrienols in the forms α, β, γ, and δ. 12. The formulation of claim 11 wherein said Vitamin E as dl-α-tocopheryl ester, said Vitamin E as d-α-tocopherol, and said Vitamin E mixed tocopherols in the forms α, β, γ, and δ is a blend of synthetic and natural sources of Vitamin E, and said tocotrienols are from a natural source. 13. The formulation of claim 11 wherein said Vitamin E as dl-α-tocopheryl ester is present at from 5 mg to 400 mg. 14. The formulation of claim 11 wherein said Vitamin E as d-α-tocopherol is present at from 5 mg to 400 mg. 15. The formulation of claim 11 wherein said Vitamin E as mixed tocopherols is present at from 5 mg to 200 mg. 16. The formulation of claim 11 wherein said Vitamin E as mixed tocotrienols in the forms α, β, γ, and δ is present at from 5 mg to 50 mg with variable composition of isomers: α tocotrienol at 1 to 30%; β tocotrienol at 0.1 to 30%; γ tocotrienol at 1 to 30%; and δ tocotrienol at 0.1 to 30%. 17. The formulation of claim 16 comprising: inseparable variable content of carotenoids comprising: alpha carotene; beta carotene; gamma carotene; lycopene; and phytosterols and squalene. 18. The formulation of claim 11 comprising: a marker selected from at least one of the group consisting of: coenzyme Q10; rosemary oil; green tea; α lipoic acid; lycopene; grape seed extract; pine bark extract; vitamin C; natural beta carotene; synthetic beta carotene; γ-oryzanol; selenium; and lutein. 19. A soft gelatin capsule formulation containing: 5 to 2000 mg d-α-tocopherol; 5 to 2000 mg of dl-α-tocopheryl ester selected from at least one of the group consisting of: dl-α-tocopheryl acetate; and dl-α-tocopheryl succinate; 5 to 2000 mg of natural mixed tocopherols comprising: α isomer; β isomer; γ isomer; and δ isomer; 5 to 500 mg of tocotrienols comprising: α isomer; β isomer; γ isomer; and δ isomer; whereby said tocotrienols are from a natural source selected from the group consisting of: rice; palm; rice bran; and soybean oil. 20. The soft gelatin capsule formulation of claim 19 wherein said Vitamin E as dl-α-tocopheryl ester, said Vitamin E as d-α-tocopherol, and said Vitamin E mixed tocopherols in the forms α, β, γ, and δ is a blend of synthetic and natural sources of Vitamin E, and said tocotrienols is from a natural source. 21. The formulation of claim 8 wherein said Vitamin E as d-α-tocopherol is present at from 5 mg to 2000 mg. 22. The formulation of claim 8 wherein said Vitamin E as mixed tocopherols is present at from 5 mg to 2000 mg. 23. The formulation of claim 8 wherein said Vitamin E as mixed tocotrienols in the forms α, β, γ, and δ is present at from 5 mg to 500 mg with variable composition of isomers: α tocotrienol at 1 to 30%; β tocotrienol at 0.1 to 30%; γ tocotrienol at 1 to 30%; and δ tocotrienol at 0.1 to 30%. 24. The formulation of claim 8 wherein said Vitamin E as dl-α-tocopheryl ester, said Vitamin E as d-α-tocopherol, and said Vitamin E mixed tocopherols in the forms α, β,